Taipei Exchange - Delayed Quote • TWD
AmCad BioMed Corporation (4188.TWO)
At close: April 26 at 1:30 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-41,599.00
-41,599.00
-34,193.00
-38,968.00
-50,048.00
Investing Cash Flow
27,311.00
27,311.00
27,140.00
49,180.00
5,918.00
Financing Cash Flow
-3,098.00
-3,098.00
-4,416.00
-11,346.00
-5,016.00
End Cash Position
29,658.00
29,658.00
47,044.00
58,513.00
59,647.00
Capital Expenditure
-293.00
-293.00
-614.00
-2,335.00
-320.00
Issuance of Capital Stock
1,320.00
1,320.00
--
--
--
Free Cash Flow
-41,892.00
-41,892.00
-34,807.00
-41,303.00
-50,368.00
12/31/2020 - 12/26/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4198.TWO S&S Healthcare Holding Ltd.
48.50
-3.77%
1799.TWO Easywell Biomedicals, Inc.
67.20
-0.44%
4161.TWO Bioptik Technology Incorporation
34.25
0.00%
4183.TWO EPS Bio Technology Corp.
21.60
+1.41%
1781.TWO Health & Life Co., Ltd.
15.30
-1.92%
4121.TWO Rossmax International Ltd.
22.50
+0.22%
4129.TWO United Orthopedic Corporation
97.20
+3.18%
4106.TW Wellell Inc.
27.80
+0.36%
6649.TWO Taiwan Biomaterial Co., Ltd.
29.95
+0.84%
4155.TW OK Biotech Co., Ltd.
25.95
+6.35%